CH581626A5 - - Google Patents

Info

Publication number
CH581626A5
CH581626A5 CH1537973A CH1537973A CH581626A5 CH 581626 A5 CH581626 A5 CH 581626A5 CH 1537973 A CH1537973 A CH 1537973A CH 1537973 A CH1537973 A CH 1537973A CH 581626 A5 CH581626 A5 CH 581626A5
Authority
CH
Switzerland
Application number
CH1537973A
Original Assignee
Science Union & Cie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Science Union & Cie filed Critical Science Union & Cie
Publication of CH581626A5 publication Critical patent/CH581626A5/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D223/00Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/18Dibenzazepines; Hydrogenated dibenzazepines
    • C07D223/22Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D223/00Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/18Dibenzazepines; Hydrogenated dibenzazepines
    • C07D223/22Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines
    • C07D223/24Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines with hydrocarbon radicals, substituted by nitrogen atoms, attached to the ring nitrogen atom
    • C07D223/26Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines with hydrocarbon radicals, substituted by nitrogen atoms, attached to the ring nitrogen atom having a double bond between positions 10 and 11
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D279/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/101,4-Thiazines; Hydrogenated 1,4-thiazines
    • C07D279/141,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
    • C07D279/18[b, e]-condensed with two six-membered rings
    • C07D279/22[b, e]-condensed with two six-membered rings with carbon atoms directly attached to the ring nitrogen atom
    • C07D279/30[b, e]-condensed with two six-membered rings with carbon atoms directly attached to the ring nitrogen atom with acyl radicals attached to the ring nitrogen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CH1537973A 1972-11-03 1973-11-01 CH581626A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB5069772A GB1399539A (en) 1972-11-03 1972-11-03 Tricyclic ureas processes for preparing them and pharma ceutical compositions containing them

Publications (1)

Publication Number Publication Date
CH581626A5 true CH581626A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1976-11-15

Family

ID=10456989

Family Applications (1)

Application Number Title Priority Date Filing Date
CH1537973A CH581626A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1972-11-03 1973-11-01

Country Status (10)

Country Link
US (1) US3925369A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JPS5516423B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE (1) BE806854A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA1037038A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH (1) CH581626A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES420225A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR (1) FR2205319B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GB (1) GB1399539A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HU (1) HU167847B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NL (1) NL161444C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4919804A (en) * 1988-03-01 1990-04-24 University Of Florida Ultrasound driven synthesis of reversed and normal phase stationary phases for liquid chromatography
AU2002322720B2 (en) 2001-07-25 2008-11-13 Raptor Pharmaceutical Inc. Compositions and methods for modulating blood-brain barrier transport
DK1889198T3 (da) 2005-04-28 2015-02-09 Proteus Digital Health Inc Farma-informatiksystem
CA2663377A1 (en) 2006-09-18 2008-03-27 Raptor Pharmaceutical Inc. Treatment of liver disorders by administration of receptor-associated protein (rap)-conjugates
CN104208718B (zh) 2009-02-20 2017-12-29 2-Bbb医疗股份有限公司 基于谷胱甘肽的药物递送系统
KR20190116576A (ko) 2009-05-06 2019-10-14 라보라토리 스킨 케어, 인크. 활성제-칼슘 포스페이트 입자 복합체를 포함하는 피부 전달 조성물 및 이들을 이용하는 방법
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
TW201236239A (en) 2010-11-16 2012-09-01 Solvay Rechargeable metal or metal-ion cell

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1257644A (fr) * 1958-03-20 1961-04-07 Geigy Ag J R Nouveaux composés dibenzo-azépiniques et leur procédé de préparation
US2965638A (en) * 1958-03-20 1960-12-20 Geigy Chem Corp Nu-substituted azepines and dihydroazepines

Also Published As

Publication number Publication date
NL161444C (nl) 1980-02-15
DE2354999A1 (de) 1974-05-22
CA1037038A (fr) 1978-08-22
JPS5516423B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1980-05-01
ES420225A1 (es) 1976-03-16
JPS4980081A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1974-08-02
BE806854A (fr) 1974-04-30
FR2205319B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1976-08-13
US3925369A (en) 1975-12-09
DE2354999B2 (de) 1977-01-13
HU167847B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1975-12-25
NL7315030A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1974-05-07
FR2205319A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1974-05-31
GB1399539A (en) 1975-07-02
NL161444B (nl) 1979-09-17

Similar Documents

Publication Publication Date Title
JPS4980081A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JPS4921107U (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CS161278B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CS159425B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CS154077B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CS161021B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CS160875B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CS160870B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CS159541B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CS162157B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CS156838B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CS156820B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CS163967B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CS156674B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CS156150B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CS155927B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH561350A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH592321A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH570149A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH570213A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH572478A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH572775A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH573640A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH574243A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH576991A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Legal Events

Date Code Title Description
PL Patent ceased
PL Patent ceased